International Journal of Medical Science and Pharmaceutical Research

Introduction: Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by heterogeneous clinical manifestations and the potential for irreversible organ damage. Despite advances in pharmacological treatment, many patients continue to experience persistent symptoms, adverse effects, and reduced quality of life. Acupuncture has been proposed as a complementary therapy aimed at pain relief, immune modulation, and functional improvement.

Objective: To critically review the efficacy and safety of acupuncture in the management of SLE, integrating recent clinical evidence, including randomized controlled trials, systematic reviews, case reports, and observational studies.

Methods: A systematized narrative review was conducted using international databases, without language restrictions, up to September 2025. Randomized controlled trials, systematic reviews, meta-analyses, and clinical case reports were included.

Results: Seven clinical trials, one meta-analysis including 514 patients, and multiple case reports were identified. The studies demonstrated significant improvements in pain, fatigue, quality of life, and laboratory markers such as anti-dsDNA and complement levels, particularly when acupuncture was combined with conventional therapy. The meta-analysis also showed a reduction in adverse events compared to pharmacological treatment alone. However, heterogeneity in acupuncture protocols and methodological limitations reduce the strength of the evidence.

Conclusion: Acupuncture represents a promising adjunctive intervention in the treatment of SLE; however, robust multicenter studies are needed to confirm its efficacy and establish standardized protocols.

systemic lupus erythematosus; acupuncture; complementary therapy; autoimmunity; quality of life.

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011 Dec 1;365(22):2110-21. doi: 10.1056/NEJMra1100359. PMID: 22129255.
2. Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016 Jun 16;2:16039. doi: 10.1038/nrdp.2016.39. PMID: 27306639.
3. Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762. PMID: 37827694.
4. Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, et al; GLADEL. Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. PMID: 25697768.
5. Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, et al; Acupuncture Trialists' Collaboration. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med. 2012 Oct 22;172(19):1444-53. doi: 10.1001/archinternmed.2012.3654. PMID: 22965186; PMCID: PMC3658605.
6. MacPherson H, Vertosick EA, Foster NE, Lewith G, Linde K, Sherman KJ, et al; Acupuncture Trialists' Collaboration. The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain. Pain. 2017 May;158(5):784-793. doi: 10.1097/j.pain.0000000000000747. PMID: 27764035; PMCID: PMC5393924.
7. Vas J, Santos-Rey K, Navarro-Pablo R, Modesto M, Aguilar I, Campos MÁ, et al. Acupuncture for fibromyalgia in primary care: a randomised controlled trial. Acupunct Med. 2016 Aug;34(4):257-66. doi: 10.1136/acupmed-2015-010950. Epub 2016 Feb 15. PMID: 26879181.
8. Greco CM, Kao AH, Maksimowicz-McKinnon K, Glick RM, Houze M, Sereika SM, et al. Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study. Lupus. 2008 Dec;17(12):1108-16. doi: 10.1177/0961203308093921. PMID: 19029279; PMCID: PMC3633212.
9. Wang H, Wang B, Huang J, Yang Z, Song Z, Zhu Q, Xie Z, Sun Q, Zhao T. Efficacy and safety of acupuncture therapy combined with conventional pharmacotherapy in the treatment of systemic lupus erythematosus: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 6;102(40):e35418. doi: 10.1097/MD.0000000000035418. PMID: 37800775; PMCID: PMC10552960.
10. Donoyama N, Ohkoshi N. Electroacupuncture therapy for arthralgia and Raynaud's phenomenon in a patient with systemic lupus erythematosus. Acupunct Med. 2010 Mar;28(1):49-51. doi: 10.1136/aim.2009.001529. PMID: 20351379.
11. Mooventhan A, Nivethitha L. Effects of acupuncture and massage on pain, quality of sleep and health related quality of life in patient with systemic lupus erythematosus. J Ayurveda Integr Med. 2014 Jul;5(3):186-9. doi: 10.4103/0975-9476.140484. PMID: 25336852; PMCID: PMC4204291.
12. Guo T, Chen Z, Tai X, Liu Z, Zhu M. Space-time acupuncture for intractable cough after lupus nephropathy: A case report and literature review. Medicine (Baltimore). 2017 Dec;96(51):e9309. doi: 10.1097/MD.0000000000009309. PMID: 29390501; PMCID: PMC5758203.
13. Chang CM, Wu PC, Chiang JH, Wei YH, Chen FP, Chen TJ, et al. Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study. J Ethnopharmacol. 2017 Jan 20;196:201-212. doi: 10.1016/j.jep.2016.12.016. Epub 2016 Dec 12. Erratum in: J Ethnopharmacol. 2017 Jul 12;206:426. doi: 10.1016/j.jep.2017.05.025. PMID: 2797423
14. Lu MC, Lo HC, Chang HH, Hsu CW, Koo M. Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study. BMC Complement Med Ther. 2021 Oct 1;21(1):247. doi: 10.1186/s12906-021-03416-w. PMID: 34598699; PMCID: PMC8485480.
15. Kung YY, Chen FP, Hwang SJ. The different immunomodulation of indirect moxibustion on normal subjects and patients with systemic lupus erythematosus. Am J Chin Med. 2006;34(1):47-56. doi: 10.1142/S0192415X0600362X. PMID: 16437738.
16. Heng M, Tu J, Hao Y, Zhao Y, Tian J, Bu H, Wang H. Effects of Integrated Traditional Chinese and Western Medicine for the Treatment of Lupus Nephritis: A Meta-Analysis of Randomized Trials. Evid Based Complement Alternat Med. 2016;2016:1502107. doi: 10.1155/2016/1502107. Epub 2016 Dec 26. PMID: 28105057; PMCID: PMC5220491.